CID 72202701

Bozitinib

Structural Information

Molecular Formula
C20H15F3N8
SMILES
CN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F
InChI
InChI=1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3
InChIKey
QHXLXUIZUCJRKV-UHFFFAOYSA-N
Compound name
6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

280
Patents

424.13718 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 425.14446 196.7
[M+Na]+ 447.12640 210.0
[M+NH4]+ 442.17100 200.5
[M+K]+ 463.10034 210.5
[M-H]- 423.12990 201.5
[M+Na-2H]- 445.11185 204.1
[M]+ 424.13663 200.8
[M]- 424.13773 200.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe